These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2959933)

  • 21. Acute psychosis after mefloquine. Report of six cases.
    Sowunmi A; Adio RA; Oduola AM; Ogundahunsi OA; Salako LA
    Trop Geogr Med; 1995; 47(4):179-80. PubMed ID: 8560592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Convulsions during prophylactic use of mefloquine].
    Heeringa M; Kuster JA; Meyboom RH; Bouvy M
    Ned Tijdschr Geneeskd; 1998 Nov; 142(45):2477-80. PubMed ID: 10028330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
    Botero D; Restrepo M; Montoya A
    Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute cerebral disorders following high doses of an oxyquinoline derivative].
    Kaeser HE; Scollo-Lavizzari G
    Dtsch Med Wochenschr; 1970 Feb; 95(8):394-7. PubMed ID: 5461084
    [No Abstract]   [Full Text] [Related]  

  • 25. Mefloquine adverse effects with atypical facial lesions in an overweight patient.
    Descloux E; De Monbrison F; Basselin C; Vial T; Peyron F
    Travel Med Infect Dis; 2010 Sep; 8(5):318-21. PubMed ID: 20971443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant atrioventricular conduction triggered by antimalarial prophylaxis with mefloquine.
    Richter J; Burbach G; Hellgren U; Dengler A; Bienzle U
    Lancet; 1997 Jan; 349(9045):101-2. PubMed ID: 8996427
    [No Abstract]   [Full Text] [Related]  

  • 27. [Mefloquine: neuropsychiatric adverse effects are often severe and persistent long after withdrawal of the drug].
    Jensen JJ
    Ugeskr Laeger; 1998 Apr; 160(16):2413. PubMed ID: 9616091
    [No Abstract]   [Full Text] [Related]  

  • 28. Case study: neuropsychiatric symptoms associated with the antimalarial agent mefloquine.
    Clattenburg RN; Donnelly CL
    J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1606-8. PubMed ID: 9394947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind comparative clinical trial of mefloquine and chloroquine in symptomatic falciparum malaria.
    Kofi Ekue JM; Ulrich AM; Rwabwogo-Atenyi J; Sheth UK
    Bull World Health Organ; 1983; 61(4):713-8. PubMed ID: 6354507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase II clinical trial of mefloquine in Brazilian male subjects.
    de Souza JM
    Bull World Health Organ; 1983; 61(5):815-20. PubMed ID: 6360401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malaria, mefloquine and the mind.
    Ingram RJ; Ellis-Pegler RB
    N Z Med J; 1997 Apr; 110(1042):137-8. PubMed ID: 9152353
    [No Abstract]   [Full Text] [Related]  

  • 32. Mefloquine prophylaxis--revisited.
    Cohen J
    Aust Fam Physician; 1997 Aug; 26(8):909. PubMed ID: 9267055
    [No Abstract]   [Full Text] [Related]  

  • 33. Mefloquine-induced paranoid psychosis and subsequent major depression in a 25-year-old student.
    Dietz A; Frölich L
    Pharmacopsychiatry; 2002 Sep; 35(5):200-2. PubMed ID: 12237793
    [No Abstract]   [Full Text] [Related]  

  • 34. [Harmful effects of common drugs on the visual apparatus. Synthetic antimalarials].
    Dralands L
    Bull Soc Belge Ophtalmol; 1972; 160(1):431-6. PubMed ID: 5047224
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of mefloquine in epileptic patients.
    Jallon P
    J Neurol Neurosurg Psychiatry; 1988 May; 51(5):732. PubMed ID: 3261325
    [No Abstract]   [Full Text] [Related]  

  • 36. Mefloquine and scuba diving.
    Wright D
    N Z Med J; 1995 Dec; 108(1013):514. PubMed ID: 8532239
    [No Abstract]   [Full Text] [Related]  

  • 37. Mefloquine--a brief review.
    Ruff T
    Aust Fam Physician; 1996 May; 25(5):793. PubMed ID: 8935556
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparative clinical study of mefloquine and chloroquine in the treatment of vivax malaria.
    Alcantara AK; Uylangco CV; Sangalang RP; Cross JH
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):534-8. PubMed ID: 3915155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-dose kinetics of mefloquine in Brazilian male subjects.
    de Souza JM; Heizmann P; Schwartz DE
    Bull World Health Organ; 1987; 65(3):353-6. PubMed ID: 3499250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro sensitivity of Plasmodium falciparum isolates from Burma to chloroquine quinine and mefloquine.
    Lwin M; Zaw M
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):453-8. PubMed ID: 2937157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.